The evaluation and prediction of the ecologic impact of antibiotics in human phase I and II trials

Clinical Microbiology and Infection

Volumn 7, Issue SUPPL. 5, 2001, Pages 37-41

  Edlund, C ^a,b   Nord, C E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SÖDERTÖRN UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIUM; DRUG EFFECT; ECOSYSTEM; EVALUATION; FORECASTING; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREDICTION AND FORECASTING; REVIEW; STATISTICS;

ANTI-BACTERIAL AGENTS; BACTERIA; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; ECOSYSTEM; EVALUATION STUDIES; FORECASTING; HUMANS; MICROBIAL SENSITIVITY TESTS; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; STATISTICS;

EID: 0035757356     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2001.00072.x     Document Type: Article

References (33)

1. Tannock GW. The normal microflora - an introduction. In: Medical Importance of Normal Microflora (Tannock GW, ed.), pp 1-23. London: Kluwer Academic Publishers, 1999.
2. Edlund C, Nord CE. Ecological impact of antimicrobial agents on human intestinal microflora. Alpe Adria Microbiol J 1993; 3: 137-64.
3. Hoiby N, Pers C, Johansen HK, Hansen H & the Copenhagen Study Group on Antibiotics in Sweat. Excretion of β-lactam antibiotics in sweat - a neglected mechanism for development of antimicrobial resistance? Antimicrobial Agents Chemotherapy 2000; 44: 2855-7.
4. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264: 375-82.
5. Salyers AS, Shoemaker ND. Resistance gene transfer in anaerobes: New insights, new problems. Clin Infectious Dis 1996; 23: 36-43.
6. Vollaard EJ, Clasener HAL. Colonization resistance. Antimicrobial Agents Chemotherapy 1994; 38: 409-14.
7. Edlund C, Barkholt L, Olsson-Liljequist B, Nord CE. Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infectious Dis 1997; 25: 729-32.
8. Lund B, Edlund C, Barkholt L, Tvede M, Poulsen RL. Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin. Scand J Infections Dis 2000; 32: 627-32.
9. Oh H, Nord CE, Barkholt L, Hedberg M, Edlund C. Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone. Infection 2000; 28: 272-7.
10. Edlund C, Beyer G, Hiemer-Bau M, Ziege S, Lode H, Nord CE. Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand J Infections Dis 2000; 32: 81-5.
11. Quiding H, Arwidsson HG, Grahn Håkansson E, Grahnén A, Holm S. Saliva-resistant coating of tablets prevents oral release of penicillin: plasma but not saliva equivalence. European J Clin Pharmacol 1998; 54: 749-52.
12. Edlund C, Stark C, Nord CE. The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. J Antimicrobial Chemotherapy 1994; 34: 127-38.
13. Edlund C, Lindqvist L, Nord CE. Binding of norfloxacin to human fecal material. Rev Infectious Dis 1989; 11 (Suppl. 5): 1237-8.
14. Hoiby N, Jarlov JO, Kemp M et al Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 1997; 349: 167-9.
15. Committee for Proprietary Medicinal Products (CPMP), The European Agency for the evaluation of Medicinal Products (EMEA). Points to consider on pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products. CPMP/EWP/2655/99., 2000.
16. Edlund C, Alván G, Barkholt L, Vacheron F, Nord CE. Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora. J Antimicrobial Chemotherapy 2001; 46: 741-9.
17. Kager L, Liljeqvist L, Malmborg AS, Nord CE. Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1981; 20: 736-40.
18. Heimdahl A, Nord CE. Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract. Eur J Clin Microbiol 1982; 1: 34-48.
19. Nord CE, Gajjar DA, Grasela DM. Effect of BMS-284756, a novel Des-F(6)-quinolone antibiotic, on the normal human intestinal microflora. 40th ICAAC Abstract no. 284, Toronto, Canada: American Society for Microbiology: 2000.
20. Mackowiak Ph. The normal microbial flora. New England J Med 1982; 307: 83-93.
21. Whittaker CJ, Klier CM, Kolenbrander PE. Mechanisms of adhesion by oral bacteria. Annu Rev Microbiol 1996; 50: 513-52.
22. Lund B, Edlund C, Rynnel-Dagöö B, Lundgren Y, Sterner J, Nord CE. Comparison of ecological effects on the oro- and nasopharyngeal microflora after treatment of acute otitis media with suspensions of Co-amoxyclavulanate or cefuroxim axetil in children. Clin Microbiol Infection, 2001; 7: 230-7
23. Adamsson I, Edlund C, Seensalu R, Sjöstedt S, Nord CE. The normal gastric microflora and Helicobacter pylori; before, during and after treatment with omeprazole and amoxycillin. Clin Microbiol Infection 1998; 4: 308-15.
24. Roth RR, James WD. Microbial ecology of the skin. Annu Rev Microbiol 1998; 42: 441-64.
25. Eady EA, Jones CE, Tipper JL, Cove JH, Cuncliffe WJ. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. Br J Med 1993; 306: 555-4.
26. Sullivan Å, Edlund C, Svenungsson B, Emtestam L, Nord CE. Effect of perorally administered pivmecillinam on the normal oropharyngeal, intestinal and skin microflora. J Chemother, 2001; 13: 299-308.
27. Eschenbach DA, Thwin SS, Patton D et al Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infections Dis 2000; 30: 901-7.
28. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) A Manual of Clinical Microbiology, 7th edn. Washington, MA: American Society for Microbiology, 1999.
29. Summanen P, Baron E, Citron D, Strong C, Wexler M, Finegold S. Wadsworth Anaerobic Bacteriology Manual, 5th edn. Los Angeles, CA: Veterans Administration: Wadsworth Medical Center, 1993.
30. Tang YW, Persing DH. Molecular detection and identification of microorganisms. In: Manual of Clinical Microbiology, 7th edn (Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds). Washington, MA: American Society for Microbiology, 1999.
31. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Tests for Bacteria That Grow Aerobically; Approved Standard, 5th edn. M7-A5.20, no. 2. Villanova, PA: NCCLS, 2000.
32. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 4th edn. Approved Standard M11-A4.17, no. 22. Villanova, PA: NCCLS, 1997.
33. European Committee for Antimicrobial Susceptibiliy Testing (EUCAST). Determination of antimicrobial susceptibility test breakpoints. EUCAST Discussion Document, European Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2000.